Actively Recruiting
Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter
Led by Tang-Du Hospital · Updated on 2024-06-04
2000
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The core purpose of this study is to investigate whether the extracellular volume (ECV) fraction measured in delay phase by dual energy computed tomography (DECT) can distinguish precancerous lesions from early-stage lung adenocarcinomas, which could assist clinical decision making for surgery operation indication and strategy.
CONDITIONS
Official Title
Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients older than 18 years with pulmonary nodules 3 cm or smaller in diameter
- Pathologically confirmed lung adenocarcinoma
- No history of other malignancies
- Hematocrit measured accurately within 1 week before contrast enhanced dual energy CT examination
You will not qualify if you...
- History of allergy to iodine contrast agents or inability to complete the examination for other reasons
- No histopathology of invasion stage such as AAH, AIS, MIA, or IAC
- History of chemotherapy, radiotherapy, or other anti-tumor therapy before contrast enhanced dual energy CT
- Poor image quality
- Contrast enhanced dual energy CT scans performed 4 weeks or more before surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tangdu Hospital
Xi'an, Shaanxi, China, 710038
Actively Recruiting
Research Team
C
Cui Guangbin, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here